These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8176946

  • 21. Carcinoembryonic antigen, CA 19-9 and CA 50 in monitoring human squamous cell carcinoma of the esophagus.
    Munck-Wikland E, Kuylenstierna R, Lindholm J, Wahren B.
    Anticancer Res; 1990; 10(3):703-8. PubMed ID: 2369087
    [Abstract] [Full Text] [Related]

  • 22. [Case of submucosal esophageal carcinoma with multiple liver metastasis showing high serum levels of CEA and CA19-9].
    Kurihara T, Ishii S, Ozawa T, Tsubo K, Fukushima Y, Funatomi H, Kagaya T, Ohike N, Takahashi M.
    Nihon Shokakibyo Gakkai Zasshi; 2007 Jan; 104(1):23-9. PubMed ID: 17230002
    [Abstract] [Full Text] [Related]

  • 23. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N, Page DL, Merino MJ, Viglione MJ, Kufe DW, Schlom J.
    J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
    [Abstract] [Full Text] [Related]

  • 24. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
    Ikeda K, Terashima M, Ishida K, Okamoto K, Suzuki S, Murakami K, Ohtsu T, Suzuki K, Niitsu Y, Obonai H.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
    [Abstract] [Full Text] [Related]

  • 25. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G, Cavallini A, Piana P, Squintone L, Vottero M, Tizzani A.
    Minerva Urol Nefrol; 1992 Apr; 44(3):169-72. PubMed ID: 1492266
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer.
    Body JJ, Sculier JP, Raymakers N, Paesmans M, Ravez P, Libert P, Richez M, Dabouis G, Lacroix H, Bureau G.
    Cancer; 1990 Apr 01; 65(7):1552-6. PubMed ID: 2311066
    [Abstract] [Full Text] [Related]

  • 27. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
    Steffens J, Friedmann W, Lobeck H.
    Urol Res; 1985 Apr 01; 13(2):55-9. PubMed ID: 2409654
    [Abstract] [Full Text] [Related]

  • 28. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
    Takala H, Kauppila JH, Soini Y, Selander KS, Vuopala KS, Lehenkari PP, Saarnio J, Karttunen TJ.
    J Innate Immun; 2011 Apr 01; 3(6):631-8. PubMed ID: 21876325
    [Abstract] [Full Text] [Related]

  • 29. HLA-DR antigen expression in squamous epithelial dysplasia and squamous cell carcinoma of the esophagus: an immunohistochemical study.
    Sumiyoshi K, Kuwano H, Watanabe M, Kitamura M, Toh Y, Sugimachi K.
    Oncol Rep; 1999 Apr 01; 6(2):301-6. PubMed ID: 10022993
    [Abstract] [Full Text] [Related]

  • 30. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
    Duk JM, De Bruijn HW, Groenier KH, Fleuren GJ, Aalders JG.
    Cancer; 1990 Apr 15; 65(8):1830-7. PubMed ID: 2317761
    [Abstract] [Full Text] [Related]

  • 31. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
    Torzewski M, Sarbia M, Heep H, Dutkowski P, Willers R, Gabbert HE.
    Clin Cancer Res; 1998 Mar 15; 4(3):577-83. PubMed ID: 9533524
    [Abstract] [Full Text] [Related]

  • 32. [Usefulness of tumor markers in the diagnosis of squamous carcinoma of the esophagus].
    Pecchio F, Albertino B, Ferrarotti G, Baldi S, Adamo R, Lo Faso C, Oliaro A, Dei Poli M, Rapellino M.
    Minerva Chir; 1988 Sep 30; 43(18):1469-71. PubMed ID: 3226583
    [No Abstract] [Full Text] [Related]

  • 33. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H, Ochiai T.
    Surgery; 2003 May 30; 133(5):486-94. PubMed ID: 12773976
    [Abstract] [Full Text] [Related]

  • 34. Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients. Correlation with histopathologic and immunohistochemical variables.
    Tabuchi Y, Deguchi H, Saitoh Y.
    Cancer; 1988 Oct 15; 62(8):1605-13. PubMed ID: 3167774
    [Abstract] [Full Text] [Related]

  • 35. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
    Ohuchi N, Sato S, Akimoto M, Taira Y, Matoba N, Takahashi K, Mori S.
    Jpn J Surg; 1991 Mar 15; 21(2):129-37. PubMed ID: 1646903
    [Abstract] [Full Text] [Related]

  • 36. Altered expression of sialyl-Tn, Lewis antigens and carcinoembryonic antigen between primary and metastatic lesions of uterine cervical cancers.
    Ogawa H, Inoue M, Tanizawa O, Miyamoto M, Sakurai M.
    Histochemistry; 1992 May 15; 97(4):311-7. PubMed ID: 1618644
    [Abstract] [Full Text] [Related]

  • 37. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A, Yakushiji M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):47-54. PubMed ID: 2157782
    [Abstract] [Full Text] [Related]

  • 38. Retinoblastoma-protein (prb) expression and prognosis in squamous-cell carcinomas of the esophagus.
    zur Hausen A, Sarbia M, Heep H, Willers R, Gabbert HE.
    Int J Cancer; 1999 Dec 22; 84(6):618-22. PubMed ID: 10567909
    [Abstract] [Full Text] [Related]

  • 39. Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fraction.
    Gion M, Tremolada C, Mione R, Dittadi R, Della Palma P, Castoro C, Ruol A, Nosadini A, Peracchia A, Bruscagnin G.
    Int J Biol Markers; 1990 Dec 22; 5(1):7-13. PubMed ID: 2230354
    [Abstract] [Full Text] [Related]

  • 40. Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies.
    Sakahara H, Saga T, Endo K, Kousaka T, Hosono M, Kobayashi H, Shirato M, Konishi J.
    Br J Cancer; 1993 Nov 22; 68(5):920-5. PubMed ID: 8217607
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.